'I WOULD LIKE TO THANK CHRIS UITHOVEN, PRESIDENT OF THE NATIONAL MULTIPLE SCLEROSIS SOCIETY, ARIZONA CHAPTER FOR THE FOLLOWING INFORMATION!" Stan Swartz, Publisher
This afternoon, March 1, 2005, at 5:30 EST, MS Learn Online will present a special webcast about the recent suspension of Tysabri.
Presenters include:
Dr. John Richert, Vice President of the Research and Clinical Programs Department of the National MS Society
Dr. Aaron Miller, Chief Medical Officer of the National MS Society and Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis in New York City
Dr. Al Sandrock, Vice President for Medical Research for Biogen IDEC.
We will address common concerns and questions such as:
- Why was Tysabri suspended?
- What is PML?
- Is PML due to Avonex, Tysabri, or the combination of both?
- Is PML related to MS? Should I be tested?
- Are clinical trials being stopped?
- What does the FDA have to say about this?
****************************************
Click here today at 5:30 p.m. EST to go to webcast. This program will be continuously available on our web site after 5:30 p.m., March 1, 2005.
For more general information about Tysabri, go to the FDA web site at http://www.fda.gov/cder/drug/infopage/
natalizumab/natalizumabQA_2_2005.htm.
